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Abstract
Background: Childhood vaccination coverage can be estimated from a range of sources. This study aims to
validate vaccination data from a longitudinal population-based demographic surveillance system (DSS) against data
from a clinical cohort study.
Methods: The sample includes 821 children in the Vertical Transmission cohort Study (VTS), who were born between
December 2001 and April 2005, and were matched to the Africa Centre DSS, in northern KwaZulu-Natal. Vaccination
information in the surveillance was collected retrospectively, using standardized questionnaires during bi-annual
household visits, when the child was 12 to 23 months of age. DSS vaccination information was based on extraction
from a vaccination card or, if the card was not available, on maternal recall. In the VTS, vaccination data was collected at
scheduled maternal and child clinic visits when a study nurse administered child vaccinations. We estimated the
sensitivity of the surveillance in detecting vaccinations conducted as part of the VTS during these clinic visits.
Results: Vaccination data in matched children in the DSS was based on the vaccination card in about two-thirds of the
cases and on maternal recall in about one-third. The sensitivity of the vaccination variables in the surveillance was high
for all vaccines based on either information from a South African Road-to-Health (RTH) card (0.94-0.97) or maternal recall
(0.94-0.98). Addition of maternal recall to the RTH card information had little effect on the sensitivity of the surveillance
variable (0.95-0.97). The estimates of sensitivity did not vary significantly, when we stratified the analyses by maternal
antenatal HIV status. Addition of maternal recall of vaccination status of the child to the RTH card information
significantly increased the proportion of children known to be vaccinated across all vaccines in the DSS.
Conclusion: Maternal recall performs well in identifying vaccinated children aged 12-23 months (both in HIV-
infected and HIV-uninfected mothers), with sensitivity similar to information extracted from vaccination cards.
Information based on both maternal recall and vaccination cards should be used if the aim is to use surveillance
data to identify children who received a vaccination.
Background
Child vaccinations are among the most cost-effective
public health interventions [1] associated with significant
reductions in child mortality [2,3]. Between 2000 and
2007, child deaths from measles declined by an esti-
mated 74% globally and 89% in Africa; polio, a major
cause of disability and morbidity among children, is now
close to eradication [4]. This success is largely due to
the Expanded Programme of Immunization (EPI) which
has seen rapid scale-up of routine immunizations;
diphtheria-tetanus-pertussis (DTP3) vaccine coverage
increased from 20% to 82% and that of measles from
17% to 83% from 1980 to 2008, respectively [5].
Although more children are now protected against
vaccine-preventable diseases than ever before, in many
settings vaccination coverage is not sufficient to provide
herd protection. Measles outbreaks, for instance, con-
tinue to occur [6]. For health policymakers to assess the
need for vaccination interventions, it is important to
monitor coverage at a population level. Two methods to
estimate vaccination coverage in young children are
commonly used: administrative data, which are
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and may overestimate coverage [7]; and cross-sectional
population-based surveys which determine the percen-
tage of children vaccinated within a certain geographic
area, such as the demographic and health surveys
(DHSs) [8]. DHSs, carried out in over 75 countries, are
generally nationally representative and use a two-stage
sampling scheme, with clusters as primary sampling
units and then random selection of households within
each clusters [9]. Vaccination data, collected from the
mother (or another household member, if the mother is
absent), on all children aged 12-23 months at the time
of the interview are used in calculating coverage.
Demographic Surveillance Systems (DSSs), currently
totaling 42 in 19 countries, are another source of infor-
mation on vaccination coverage. DSSs longitudinally
track the demographic and health indicators of indivi-
duals in well-defined study areas, through household
and individual surveys [10]. Finally, clinical cohort stu-
dies documenting the vaccination status of children dur-
ing follow up have also been used to estimate
vaccination coverage [11,12]. In contrast to cross-sec-
tional surveys, vaccination data from longitudinal popu-
lation-based DSSs has never been validated.
This study investigates the sensitivity of vaccination
information collected as part of a large, longitudinal,
population-based DSS in rural South Africa. Data on
vaccinations collected in a large clinical cohort study
serves as the “gold standard” in the sensitivity
estimation.
Methods
Setting
Since 2000, households in the Africa Centre Demo-
graphic Surveillance Area (DSA), in the Umkhanyakude
district of northern KwaZulu-Natal, South Africa [13,14],
have been visited twice yearly as part of a DSS, with ques-
tionnaires administered to key household informants
recording vital events including vaccinations [14]. HIV
prevalence [15], HIV incidence [16], and HIV-related
mortality are high in the DSA [17], but mortality has
been declining in recent years due to the rapid expansion
of antiretroviral treatment [18]. HIV prevalence in
women of child-bearing age in the community is particu-
larly high with approximately 40% of pregnant women
HIV-infected [19]. In the sub-district, the health service
infrastructure includes a central district hospital, 17 fixed
primary health care clinics, and 31 mobile clinic points
[20]. The mobile clinics offer childhood vaccination in
addition to family planning advice and antenatal care.
We previously estimated vaccination coverage in the first
year of life in the DSA, which was highest for BCG, given
at birth, at 89% (95% CI 82-94) and lowest for measles
vaccine, given at 9 months, at 77% (95% CI 67-84) [21].
Survey methods
In the DSA, trained interviewers visited households and
administered a standardised questionnaire in the local
language, isiZulu [14]. Mothers, caregivers, or the head
of the household (in absence of the mother or caregiver)
were asked to show the interviewers the South African
Road-to-Health (RTH) card for all children aged 12-23
months at the time of the surveillance visit. For ease of
exposition, we henceforth refer to caregivers and heads
of household who provided information on a child’s vac-
cination status as “mother”. A child’s vaccination history
was recorded only once after the child had celebrated
their first birthday. The response rates for household
surveillance are >99% [14]. The RTH card records dates
of all routine vaccinations a child has received [22].
When a child’s RTH card was missing, interviewers
asked the mother to recall whether the child had
received each of the vaccinations included in the South
African National Immunization Schedule [23]. Informa-
tion on the clinic of first vaccination is also recorded.
This approach to elicit child vaccination status is similar
to that used by DHS [9]. The Africa Centre DSS has a
shorter duration of recall than the DHSs; the former
collects vaccination histories bi-annually, the latter
usually collects these histories every five years although
coverage is calculated on children aged 12-23 months.
Therefore, in DHSs it may be likely that vaccination
cards, especially for older children, are missing and
maternal recall will become more important as a tool.
The Vertical Transmission Study
The Vertical Transmission Study (VTS, 2001-2006)
enrolled approximately equal numbers of pregnant,
HIV-infected and uninfected women into an interven-
tion cohort study, to examine infant feeding and postna-
tal HIV transmission [24]. Women and their children
had scheduled clinic visits, monthly to 9 months after
delivery, and 3-monthly from 10-24 months after deliv-
ery. Visits coincided with times for child immunizations;
study nurses either performed the immunization them-
selves or referred the child for immunization to the
Department of Health nurse in adjacent clinic rooms.
The VTS study nurse then completed the study form
appropriately after the immunization had been given.
However, if the child had been vaccinated elsewhere,
this information was not recorded on the study form.
Children with missing vaccination information on the
VTS form were classified as ‘not vaccinated on sched-
uled visit’ in this study. For these children, we investi-
gated if they were reported as vaccinated in the DSS, as
they may have been immunized outside the VTS clinics.
This study utilized all the vaccination status information
that were either given or observed to have been given
by the VTS study nurse. Ethical approval was obtained
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of the University of KwaZulu-Natal (UKZN).
The sample includes all children in the VTS who were
born in the DSA between December 2001 and April
2005, and linked to the demographic information in the
household surveillance of the Africa Centre DSS with
follow-up to age 23 months (Figure 1). Only five of the
eight VTS recruitment clinics were located in the DSA;
and only a proportion of the women enrolled in the
VTS lived in the DSA. VTS data were linked to demo-
g r a p h i cs u r v e i l l a n c ed a t ai ns t e p s ;f i r s t l y ,w h e r ep e r f e c t
match on mother’s names, gender, national South Afri-
can identification number, and date of birth were found
in both datasets, the linkage was made automatically.
Thereafter ‘likely’ candidates for linkage, based on less
perfect matches, e.g., matching on most but not all cri-
teria, various combinations of similar-sounding names,
close dates of birth etc. were made by experienced local
staff members. Once all the mothers were matched to
the extent possible, a similar exercise was carried out to
match the children. Overall, one-third of the mothers
and one-third of the children who had, at some point
since 2000, been under the surveillance in the Africa
Centre surveillance system were successfully matched.
For a child to be matched, their mother had to have
been already matched. Ethical approval for this linkage
was obtained from BREC at UKZN.
In the DSS, vaccination by vaccine type was consid-
ered complete as per the South African National Immu-
nization Schedule [23,25] (one vaccine dose of measles;
and three doses of poliomyelitis (polio), diphtheria-teta-
nus-pertussis (DTP), and Hepatitis B (HepB)). Bacillus
Calmette-Guérin (BCG) vaccine was excluded because
this vaccination was given at birth by midwives and thus
not documented on the VTS forms whose first child
clinic visit was at 6 weeks of age. Haemophilus influen-
zae type B vaccine (Hib) was also excluded because it
was introduced in National Immunization Schedule only
VTS = Vertical Transmission Study, DSS = demographic information system 
Children in VTS linked to the DSS 
                                     N=821 
VTS vaccination information 
N=821 
DSS vaccination information 
N=821 
Vaccinated 
on scheduled 
visit 
Not vaccinated 
on scheduled 
visit 
Information 
from 
vaccination 
card 
Information 
from 
maternal 
recall 
No information 
from either 
vaccination card 
or maternal recall  
Vaccinated   Unvaccinated  
Figure 1 Flow chart of sample selection
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birth in our sample. Mother’s report was counted as a
vaccination event if the mother stated that the child had
received the respective vaccine dose. If the response to
t h ev a c c i n e - d o s eq u e s t i o nw a s“No”, “Don’tk n o w ” or
“Unknown”, the child was considered not to have
received the particular vaccine dose. This coding of vac-
cination events follows the DHS guidelines of handling
reports of vaccination [9].
Statistical analysis
We report the distribution of sources of vaccination
data among children aged 12-23 months who had
received specific vaccinations based on VTS and on DSS
information. The 12-23 months age band was chosen
because by one year of age, all children should have
received all vaccinations included in this study. This age
band is commonly used in studies of vaccination cover-
a g e[ 2 6 - 2 8 ] .W ee s t i m a t e dt h es e n s i t i v i t yo ft h eD S Si n
detecting vaccinations conducted as part of the VTS
during clinic visits. Sensitivity calculations for RTH card
only (from DSS) were based on those children whose
RTH card data and VTS data were available; sensitivity
calculations for maternal recall only (from DSS) were
based on those children whose maternal recall informa-
tion and VTS data were available. When both RTH card
and maternal recall data were available in the DSS, sen-
sitivity calculations were based on all children who had
a vaccination report in both DSS and VTS. All analyses
were performed in Stata (Version 11: Stata Corporation,
College Station, Texas, USA).
Results
T h e r ew e r e8 2 1c h i l d r e ni nt h eV T Sw i t hv a c c i n a t i o n
information, who were linked to the household surveil-
lance (Figure 1). Of these, maternal antenatal HIV status
was available for 819 children, of whom 405 (50%) were
HIV infected. The median age of the mothers was 23.9
years (IQR 20.2-29.5).
Vaccination information by data source
Table 1 shows the distribution of vaccination informa-
tion by data source. The proportion of all children in
the VTS who received vaccinations on the scheduled
study visit date was highest for Polio1 (86%, 95% confi-
dence interval (CI) 84-88) and lowest for Hepatitis B3
vaccine (48%, 95% CI 45-52).
In the DSS, 28%, 44% and 45% of infants were vacci-
nated outside the schedule at 6 (window period 5-7), 10
(9-11) and 14 (13-16) weeks respectively; over 80% of
these children received vaccinations within 30 days after
the window period. 22% of infants were vaccinated for
measles after the age of 9 months (window period 9-10
months), two-thirds of these receiving the vaccine before
the age of 2 years. Across all vaccinations, the vaccina-
tion data in matched children in the DSS was based on
the vaccination card in about two-thirds of the cases
and on maternal recall in about one-third. The addition
of maternal recall of vaccination status of the child to
the RTH card information thus significantly increased
the proportion of children known to be vaccinated
across all vaccines in the DSS. For instance, the propor-
tion of children known to have received the first dose of
the polio vaccine was 49% (95% CI, 45-52) based on
vaccination card alone, but 74% (95% CI, 71-77) based
on both maternal recall and vaccination card, p < 0.001.
The proportion of children known to have received the
measles vaccine also increased significantly from 44%
(95% CI, 41-47) to 70% (95% CI, 67-73), p < 0.001.
Between 71% and 89% of the children without infor-
mation for a particular vaccination in the DSS (from
either the RTH card or maternal recall) were reported
as having received that vaccination in the VTS, sug-
gesting that a large proportion of these children had
not previously received the vaccination prior to their
VTS scheduled clinic visits. This indicates that the
DSS performed well in identifying children who are
not vaccinated. Further, across all vaccinations, 55-65%
of the children who had not been vaccinated during
scheduled visits in the VTS had vaccination informa-
tion available in the DSS. About 80% of the children in
this group had received a particular vaccination,
according to the DSS information, indicating that VTS
performed well in avoiding duplicate vaccinations in
already vaccinated children or that vaccinations
missed in the VTS could have been picked up later
opportunistically.
Sensitivity estimation
The sensitivity of the DSS in detecting vaccinations con-
ducted as part of the VTS was high, across all vaccina-
tions, when only information from the RTH card
information was used (ranging from 0.94 to 0.97) (Table
2). Maternal recall of vaccination coverage was similarly
high across all vaccinations (ranging from 0.94 to 0.98).
As both vaccination card data and maternal recall data
were separately highly sensitive indicators of coverage of
vaccinations done in the VTS, high sensitivities at 0.95-
0.97 were noted when the two were combined together
(Table 2).
The estimates of sensitivity did not vary significantly,
when we stratified the analyses by maternal antenatal
HIV status. For instance, sensitivity based only on the
RTH card data in HIV-infected mothers ranged from
0.95 to 0.97, while it ranged from 0.94 to 0.97 in unin-
fected mothers. Similarly, using only maternal recall,
sensitivities ranged from 0.94-0.98 in both infected and
uninfected mothers.
Ndirangu et al. BMC Public Health 2011, 11:372
http://www.biomedcentral.com/1471-2458/11/372
Page 4 of 7Discussion
We find high sensitivity of maternal recall of vaccination
status in children aged 12-23 months when it is vali-
dated against data from an independent cohort study, i.
e., A positive vaccination report in the DSS will almost
always be correct. We previously showed that in the
DSS maternal HIV status was negatively associated with
vaccination uptake [21]. In this study, the estimates of
sensitivity do not vary significantly by maternal antena-
tal HIV status, so that it is unlikely that our previous
findings resulted from HIV-infected mothers being less
likely to correctly report that their children had been
vaccinated than HIV-uninfected mothers.
A limitation of the VTS data is that vaccination status
was only recorded if a vaccination was given at the sched-
uled study visit date. Therefore the total proportion of
children vaccinated in the study cannot be determined. In
this study, we thus merely investigate the sensitivity of
DSS-based vaccination information, using vaccinations
conducted as part of the VTS as “gold standard”. Future
studies should estimate the specificity of surveillance-
based vaccination records, since for many purposes it is
more important to correctly identify children who have
not received a vaccination than those who have received
it. The coverage rates should be homogenously distributed
to avoid pools of unvaccinated children. Thus, in South
Table 1 Vaccination information by source for children aged 12-23 months (n = 821)
VTS vaccination
information
DSS vaccination information
Vaccine Vaccinated on scheduled
visit
Vaccination card Maternal recall No information from either vaccination card or
maternal recall
Yes No Vaccinated Unvaccinated
Polio1 708 113 401 210 62 148
DTP1 708 113 401 208 64 148
HepB1 702 119 402 201 71 147
Polio2 614 207 405 134 44 238
DTP2 614 207 403 136 44 238
HepB2 583 238 404 134 44 239
Polio3 459 362 395 135 45 246
DTP3 459 362 395 137 44 245
HepB3 397 424 396 137 45 243
Measles 461 360 361 213 76 171
The numbers in the cells represent the counts of children with vaccination information from a particular source. VTS = Vertical transmission study, DSS =
demographic information system.
Table 2 Sensitivity of vaccination record comparing VTS (gold standard) to DSS vaccination information
DSS (Card data only) DSS (Maternal recall data only) DSS (Card plus maternal recall)
Vaccination Sensitivity 95% CI N Sensitivity 95% CI N Sensitivity 95% CI N
Polio1 0.97 (0.95-0.98) 395 0.96 (0.91-0.98) 204 0.97 (0.95-0.98) 599
DTP1 0.97 (0.94-0.98) 395 0.98 (0.95-0.99) 201 0.97 (0.95-0.98) 596
HepB1 0.96 (0.94-0.97) 395 0.97 (0.94-0.99) 195 0.96 (0.94-0.97) 590
Polio2 0.97 (0.95-0.98) 384 0.97 (0.92-0.99) 128 0.97 (0.95-0.98) 512
DTP2 0.97 (0.95-0.98) 382 0.97 (0.92-0.99) 130 0.97 (0.95-0.98) 512
HepB2 0.97 (0.95-0.98) 384 0.97 (0.94-0.99) 128 0.97 (0.95-0.98) 512
Polio3 0.97 (0.94-0.98) 376 0.95 (0.89-0.98) 129 0.96 (0.94-0.98) 505
DTP3 0.96 (0.93-0.98) 376 0.96 (0.90-0.98) 130 0.96 (0.94-0.98) 506
HepB3 0.96 (0.94-0.97) 375 0.94 (0.89-0.98) 131 0.96 (0.94-0.97) 506
Measles 0.94 (0.91-0.97) 350 0.96 (0.91-0.98) 191 0.95 (0.92-0.97) 541
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76-83% from 1996-2004 [29], and heterogeneously distrib-
uted [21], measles outbreaks were reported in 2010, indi-
cating that there is an urgent need to identify children
who have not received the measles vaccination [30].
A general limitation of our study design is that we
only investigate the sensitivity of information collected
as part of a longitudinal demographic surveillance in
detecting vaccinations given in a clinical study - i.e., the
design does not allow us to directly investigate the sen-
sitivity of the surveillance information in detecting vac-
cinations given on other dates in other settings, such as
antenatal clinics, mobile clinics or general primary
healthcare facilities. However, it seems unlikely that the
sensitivities of detecting vaccinations given on other
dates should be much different from the ones estimated
in this study for the VTS vaccinations. First, the process
of obtaining information about the VTS vaccinations
was the same as the one for a vaccination given in any
other setting (extracting information from the RTH card
and eliciting maternal recall of vaccinations, if the RTH
card was not available). Second, with the exception of
mother’s VTS participation, all eligibility criteria for
children’s inclusion in this study were the same as the
ones for inclusion in the DSS, in which information on
vaccinations given at occasions other than the scheduled
VTS visits is available. Finally, the participation rate of
eligible mothers in the VTS was extremely high, indicat-
ing the study participants are unlikely to differ substan-
tially from the rest of the mothers in the DSS, whose
children did not have the opportunity to receive vacci-
nations through VTS.
T h eD S Sc o v e r st h ee n t i r ep o p u l a t i o nr e s i d e n ti nt h e
Africa Centre DSA. Almost all of the households in the
DSA participate in the surveillance, i.e., the DSS data
are unlikely to suffer from selection biases. While it is
possible that the pregnant women who chose to partici-
pate in the VTS are not a random sample of all preg-
nant women in the DSA, it is unlikely that VTS sample
was highly selected: almost all pregnant women in the
DSA present for antenatal visits [31,32], and the VTS
participation rate of antenatal attendees women was
>80% [25].
Conclusions
It is important to accurately estimate vaccination cover-
age to monitor the performance of the health system
[33,34]; to establish the links between vaccination capa-
city [35], coverage, disease occurrence, and the eco-
nomic benefits of vaccination [36,37]; and to provide a
framework for future coverage goals. Our result that the
sensitivity of both maternal recall and information
extracted from vaccination cards is near-perfect implies
that estimates of vaccination coverage based on either
one of these two information sources, or on both
sources jointly, are unlikely to be downward biased,
increasing our confidence in estimates of vaccination
coverage based on DSS and DHS data.
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